Immunosuppressive Medication and Non-Rejection-Related Complications Following Heart Transplantation

1. Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ. The Registry of the International Society for Heart and Lung Transplantation: eighteenth Official Report-2001. J Heart Lung Transplant. 2001;20:805-815.10.1016/S1053-2498(01)00323-0Search in Google Scholar

2. Mangini S, Alves BR, Silvestre OM, et al. Heart transplantation: review. Einstein (Sao Paulo). 2015;13:310-318.10.1590/S1679-45082015RW3154494382926154552Search in Google Scholar

3. Custódio IL, Lima FE, Lopes MV, et al. Results of medium-term survival in patients undergoing cardiac transplantation: institutional experience. Rev Bras Cir Cardiovasc. 2013;28:470-476.10.5935/1678-9741.20130077438943824598951Search in Google Scholar

4. Fiorelli AI, Coelho GHB, Oliveira Junior JL, Oliveira AS. Heart failure and heart transplantation. Rev Med. 2008; 87:105-120.Search in Google Scholar

5. Aranda JM Jr, Hill J. Cardiac transplant vasculopathy. Chest. 2000;118:1792-1800.10.1378/chest.118.6.179211115475Search in Google Scholar

6. Wilhelm MJ. Long-term outcome following heart transplantation: current perspective. J Thorac Dis. 2015;7:549-551.Search in Google Scholar

7. Lund LH, Edwards LB, Kucheryavaya AY, et al. The registry of the International Society for Heart and Lung Transplantation: thirty-first official adult heart transplant report – 2014; focus theme: retransplantation. J Heart Lung Transplant. 2014;33:996-1008.Search in Google Scholar

8. Marchetti P. New-onset diabetes after transplantation. J Heart Lung Transplant. 2004;23(5 Suppl):S194-S201.10.1016/j.healun.2004.03.00715093805Search in Google Scholar

9. Moro JA, Martínez-Dolz L, Almenar L, et al. Impacto de la diabetes mellitus en el paciente con trasplante cardiaco [Impact of diabetes mellitus on heart transplant recipients]. Rev Esp Cardiol. 2006;59:1033-1037.10.1157/1309398017125713Search in Google Scholar

10. Patel J, Kittleson M, Czer L, et al. Severity of Hypertension After Heart Transplant: Does It Impact Outcome? J Heart Lung Transplant. 2016;35:S295.10.1016/j.healun.2016.01.840Search in Google Scholar

11. Aparicio LS, Alfie J, Barochiner J, et al. Hypertension: the neglected complication of transplantation. International Scholarly Research Notices. 2013:165937.10.5402/2013/165937Search in Google Scholar

12. Han SY, Mun KC, Choi HJ, et al. Effects of cyclosporine and tacrolimus on the oxidative stress in cultured mesangial cells. Transplant Proc. 2006;38:2240-2241.10.1016/j.transproceed.2006.06.07816980053Search in Google Scholar

13. Herlitz H, Lindelöw B. Renal failure following cardiac transplantation. Nephrol Dial Transplant. 2000;15:311-314.10.1093/ndt/15.3.31110692514Search in Google Scholar

14. Straathof K, Anoop P, Allwood Z, et al. Long-term outcome following cyclosporine-related neurotoxicity in paediatric allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant. 2017;52:159-162.10.1038/bmt.2016.232522013327643866Search in Google Scholar

15. van Hooff JP, Christiaans MH, van Duijnhoven EM. Evaluating mechanisms of post-transplant diabetes mellitus. Nephrol Dial Transplant. 2004;19:vi8-vi12.10.1093/ndt/gfh106315575024Search in Google Scholar

16. Øzbay A. Diabetogenicity of Cyclosporine and Tacrolimus (Doctoral dissertation). Faculty of Health Sciences, Aarhus University; 2011.Search in Google Scholar

17. Kockx M, Kritharides L. Cyclosporin A-induced hyperlipidemia. In: Lipoproteins-Role in Health and Diseases. Rijeka: InTech Publishers, 2012; p. 337-354.Search in Google Scholar

18. Youn JC, Stehlik J, Wilk AR, et al. Temporal Trends of De Novo Malignancy Development After Heart Transplantation. J Am Coll Cardiol. 2018;71:40-49.10.1016/j.jacc.2017.10.07729301626Search in Google Scholar

19. Kumarasinghe G, Lavee O, Parker A, et al. Post transplant lymphoproliferative disease in heart and lung transplantation: defining risk and prognostic factors. J Heart Lung Transplant. 2015;34:1406-1414.10.1016/j.healun.2015.05.02126279197Search in Google Scholar

20. Mancini D, Rakita V. Malignancy Post Heart Transplantation. J Am Coll Cardiol. 2018;71:50-52.10.1016/j.jacc.2017.11.02729301627Search in Google Scholar

21. Simonenko M, Fedotov P, Sazonova Y, et al. Thyroid Disorders in Recipients After Heart Transplantation. Transplantation. 2018;102:826.10.1097/01.tp.0000543874.50643.caSearch in Google Scholar

22. Jha V. Post-transplant infections: An ounce of prevention. Indian J Nephrol. 2010;20:171-178.10.4103/0971-4065.73431300894421206677Search in Google Scholar

23. Montoya JG, Giraldo LF, Efron B, et al. Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center. Clin Infect Dis. 2001;33:629-640.10.1086/32273311486285Search in Google Scholar

24. Rostad CA, Wehrheim K, Kirklin JK, et al. Bacterial infections after pediatric heart transplantation: Epidemiology, risk factors and outcomes. J Heart Lung Transplant. 2017;36:996-1003.10.1016/j.healun.2017.05.00928583371Search in Google Scholar

25. Guggenbichler JP, Assadian O, Boeswald M, Kramer A. Incidence and clinical implication of nosocomial infections associated with implantable biomaterials – catheters, ventilator-associated pneumonia, urinary tract infections. GMS Krankenhhyg Interdiszip. 2011;6:Doc18.Search in Google Scholar

26. Echenique IA, Angarone MP, Rich JD, Anderson AS, Stosor V. Cytomegalovirus infection in heart transplantation: A single center experience. Transpl Infect Dis. 2018;20:e12896.10.1111/tid.1289629602266Search in Google Scholar

27. Carratalà J, Montejo M, Pérez-Romero P. Infections caused by herpes viruses other than cytomegalovirus in solid organ transplant recipients. Enferm Infecc Microbiol Clin. 2012;30:63-69.10.1016/S0213-005X(12)70084-8Search in Google Scholar

28. Kirklin JK, Naftel DC, Levine TB, et al. Cytomegalovirus After Heart Transplantation. Risk Factors for Infection and Death: A Multiinstitutional Study. The Cardiac Transplant Research Database Group. J Heart Lung Transplant. 1994;13:394-404.Search in Google Scholar